Niro Ramachandran - Feb 15, 2023 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Chief Business Officer
Signature
/s/ Niro Ramachandran, Ph.D., by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Feb 15, 2023
Transactions value $
$30,940
Form type
4
Date filed
2/17/2023, 04:10 PM
Previous filing
Apr 14, 2022
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Options Exercise $30.9K +34K +27.71% $0.91* 157K Feb 15, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKYA Employee Stock Option (Right to Buy) Options Exercise $0 -34K -35.21% $0.00 62.6K Feb 15, 2023 Common Stock 34K $0.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as follows: one-fourth (1/4) of the shares on July 13, 2021 and the remaining shares shall vest in 36 equal monthly installments beginning on July 13, 2021, until fully vested, subject to reporting person's continuous employment.